DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,000 | -70.6% | 991 | 0.0% | 0.00% | -77.8% |
| Q3 2021 | $34,000 | -5.6% | 991 | 0.0% | 0.01% | -64.0% |
| Q2 2021 | $36,000 | -18.2% | 991 | 0.0% | 0.02% | -21.9% |
| Q1 2021 | $44,000 | -22.8% | 991 | 0.0% | 0.03% | -28.9% |
| Q4 2020 | $57,000 | +11.8% | 991 | 0.0% | 0.04% | +4.7% |
| Q3 2020 | $51,000 | -13.6% | 991 | 0.0% | 0.04% | -23.2% |
| Q2 2020 | $59,000 | +43.9% | 991 | 0.0% | 0.06% | +24.4% |
| Q1 2020 | $41,000 | -33.9% | 991 | 0.0% | 0.04% | -18.2% |
| Q4 2019 | $62,000 | +82.4% | 991 | 0.0% | 0.06% | +71.9% |
| Q3 2019 | $34,000 | +54.5% | 991 | 0.0% | 0.03% | +60.0% |
| Q2 2019 | $22,000 | -4.3% | 991 | 0.0% | 0.02% | +53.8% |
| Q1 2019 | $23,000 | +9.5% | 991 | 0.0% | 0.01% | +8.3% |
| Q4 2018 | $21,000 | -44.7% | 991 | 0.0% | 0.01% | -29.4% |
| Q3 2018 | $38,000 | -2.6% | 991 | 0.0% | 0.02% | -5.6% |
| Q2 2018 | $39,000 | – | 991 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |